STIM SEC Filings: 8-K, 10-Q, S-3 & 424B – Neuronetics

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 4, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 11, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 5, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Mar 17, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 4, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 5, 2025

News

TYPE

HEADLINE

FILED AT

8-K

Neuronetics Reports Third Quarter 2026 Financial and Operating Results

Nov 4, 2026

8-K

Neuronetics, Inc. Announces Changes to Executive Leadership Team

Aug 17, 2026

8-K

Neuronetics Reports Second Quarter 2026 Financial Results and Leadership Appointments

Aug 11, 2026

8-K

Neuronetics Announces Executive Leadership Changes

Jul 20, 2026

8-K

Neuronetics, Inc. Announces Promotion of Cory Anderson to Executive Vice President, General Manager of Greenbrook

Jun 23, 2026

8-K

Neuronetics, Inc. Announces Results of 2026 Annual Meeting of Stockholders

May 29, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B5

August 2025 ATM

Aug 6, 2025

424B5

Form 424B5 - Prospectus [Rule 424(b)(5)]

Feb 10, 2025

424B5

Form 424B5 - Prospectus [Rule 424(b)(5)]

Feb 6, 2025

424B5

4,840,000 Shares-

Feb 1, 2021

424B5

3,500,000 Shares of Common Stock-

Jan 28, 2021

424B4

Risks Related to This Offering and Ownership of Our Common Stock

Jun 29, 2018

Registrations

TYPE

HEADLINE

FILED AT

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Aug 11, 2026

S-3

SHARE RESALE REGISTRATION

Mar 17, 2026

S-3

July 2025 SHELF

Jul 3, 2025

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Feb 4, 2025

S-3/A

SHELF | Offering amount: $125,000,000.00 EFFECTIVE

Nov 9, 2022

S-3

SHELF | Offering amount: $125,000,000.00 EFFECTIVE

Aug 5, 2022

Proxies

TYPE

HEADLINE

FILED AT

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 9, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 9, 2026

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 10, 2025

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 10, 2025

PRE 14A

Form PRE 14A - Other preliminary proxy statements

Mar 27, 2025

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Nov 1, 2024

Ownerships

TYPE

HEADLINE

FILED AT

Chernett Jorey (Reporting)

Nov 2, 2026

SCHEDULE 13D/A

Chernett Jorey (Filed by)

Aug 24, 2026

144

Form 144 - Report of proposed sale of securities

Aug 19, 2026

144

Form 144 - Report of proposed sale of securities

Aug 18, 2026

Chernett Jorey (Reporting)

Aug 17, 2026

SCHEDULE 13G

Point72 Asset Management, L.P. (Filed by)

Aug 14, 2026

Other

TYPE

HEADLINE

FILED AT

Form SD - Specialized disclosure report

May 29, 2026

EFFECT

Form EFFECT - Notice of Effectiveness

Apr 13, 2026

CORRESP

Form CORRESP - Correspondence

Apr 8, 2026

LETTER

Form UPLOAD - SEC-generated letter

Mar 18, 2026

EFFECT

Form EFFECT - Notice of Effectiveness

Jul 21, 2025

CORRESP

Form CORRESP - Correspondence

Jul 16, 2025

Neuronetics, Inc. STIM · SEC Filings